💾 ​​Is Qualcomm Veoneer’s Chosen One?

Novavax's delay, Beyond Meat's losses mount.


Hey Global Investor! Here’s what you need to know before the US markets open.

Market Snapshot 📈

S&P 500 (Thursday’s Close) 4,429.10 +26.44 (0.60%)

NASDAQ (Thursday’s Close) 14,895.12 +114.58 (0.78%)

FTSE 100 (5 PM IST) 7,122.58 +2.30 (0.03%)

NIFTY 50 (Today’s Close) 16,238.20 -56.40 (0.35%)

USDINR (Today’s Close) 74.13 (1 Year -1.26%)


🔥 Top Movers

SITM +31.21%
VNE +28.48%
CCRN +24.70%

INGN -26.71%
ITRI -26.44%
KPTI -24.17%


💾​​ Qualcomm: White Knight In Shining Armor?

Listen to this on Winvesta Podcast

Qualcomm (QCOM) has made its intentions clear by putting in a higher bid for Veoneer (VNE) than what Magna (MGA) had come in with less than ten days back. Given its 21% premium over Magna’s price, it’s a hard-to-overlook deal for Veoneer’s shareholders. The chip is now in Veoneer’s court. (Tweet This)

To Kill With Intrigue

On July 26, Magna International had made a bid to acquire Veoneer for $3.8B in cash. It was hoping to bolster its Advanced Driver Assistance Systems (ADAS) business through this acquisition. However well-intentioned the plan was, shareholders weren’t impressed, and Magna’s stock fell on this announcement.

Enter Qualcomm. Out of the blue, it rolled out an offer to acquire Veoneer for $4.6B in cash, a 21% premium compared to what Magna had in mind. So what does a company that manufactures chipsets for mobile phones have to do with a company that deals with ADAS systems and automated driving?

Turns out Qualcomm has an automotive electronics business that has now reached a $1B run rate annually. Its design win pipeline is over $10B. And the company has been on the prowl to add to its capabilities as it looks to put daylight between itself and the competition in the global ADAS market.

Qualcomm isn’t new to such overtures, nor is the company shy in voicing its opposition to deals out there. For instance, the company has been a vocal critic of NVIDIA’s (NVDA) proposed acquisition of ARM for $40B. In fact, it has put a counter-proposal out to invest in ARM along with a clutch of investors and take the company public.

So why this fierce opposition to NVIDIA? Self-preservation. If the deal were to go through, Qualcomm’s CDMA business which contributes 70% of the company’s revenue, would be severely impacted. With news making rounds that the UK’s regulator may be opposed to NVIDIA’s acquisition of ARM, it seems Qualcomm can afford to breathe a bit easier and focus on other escapades.

With $7.4B in cash in its balance sheet, Qualcomm has the wherewithal to pull the Veoneer deal off and doesn’t require shareholder approval. Given that Veoneer’s board has already approved the Magna deal, it’s clear they need to reconsider their decision, given the board’s fiduciary responsibilities to the shareholders.

Name Of The Game: Self-Preservation

Qualcomm has been involved with Veoneer in the past if only to pip NVIDIA. Last August, Qualcomm had announced a collaboration with Veoneer to deliver scalable ADAS and Autonomous Driving solutions and signed an agreement to that effect in January. NVIDIA was the loser since the agreement was predicated on Veoneer ending its partnership with NVIDIA.

Developments on the Veoneer front will take some pressure off Qualcomm’s mobile phone business. For instance, Google announced last week that its Pixel 6 and Pro smartphones would do away with Qualcomm’s chips in favor of its own in-house-built chips. Qualcomm, for its part, put up a brave face that this announcement won’t mean much.

Similarly with Apple. While they’ve had a love-hate relationship all along and have fought over IP issues, the two companies have buried the hatchet temporarily. With Apple acquiring Intel’s 5G smartphone chip business in 2019 for $1B, the day is not far before Qualcomm is shut out of iPhones as well.

It seems unlikely that Magna will make a counteroffer unless it’s desperate to prove it’s no pushover. In fact, the analyst community has chimed in with its opinion that Qualcomm is a better suitor for Veoneer given the strategic interests.

However, things pan out; it’s Veoneer’s shareholders that are making the hay while the sun shines. Less than two weeks ago, the shares were languishing around the $20 mark. Yesterday, they broke the $40 mark. It seems Sleeping Beauty is wide awake and ready to say yes to the White Knight in the shining armor!

Market Reaction
QCOM ended at $146.83, down 0.94%, while VNE ended at $40.15, up 28.48%.

Company Snapshot 📈

QCOM $146.83 -1.39 (0.94%)

Analyst Ratings (29 Analysts) BUY 66%  HOLD 31%  SELL 3%


Newsworthy 📰

Later: Novavax delays Covid vaccine emergency authorization submission to FDA until the fourth quarter (NVAX -9.79%)

Acquisition: Levi Strauss to buy apparel brand Beyond Yoga, launching into active wear (LEVI +0.99%)

Weakness: Beyond Meat’s loss widens amid higher costs; shares fall as pandemic clouds outlook (BYND -4.57%)


Later Today 🕒

  • Dominion Energy Inc. Earnings (D)
  • Liberty Broadband Corp Earnings (LBRDA)
  • Magna Inc. Earnings (MGA)
  • Ventas Inc. Earnings (VTR)
  • 6:00 PM IST: Nonfarm Payrolls & Unemployment Rate
  • 7:30 PM IST: Wholesale Inventories

Fun Fact of The Day 🌞

Coca Cola owns all the domain names that can be read as ‘ahh’ all the way up to 62 h’s


Disclaimer: The content of this article has been created and published by Winvesta India Technologies Pvt. Ltd., in order to ease the reader’s understanding of the subject matter. The information and/or content (collectively “Information”) provided herein is general information sourced through various news reports and does not constitute a research report or a research analysis. The Information is not intended to offer advice, target or solicit any particular customer or group of customers to buy or sell securities. 

Winvesta does not render any research or advisory services and provides a more detailed description of its services on its website and mobile application along with the terms and conditions published therein from time to time. While reasonable care has been exercised to ensure that the Information is adequate and reliable, no representation is made by Winvesta as to its accuracy or completeness and Winvesta, its affiliates, subsidiaries and employees accept no liability of whatsoever nature for any direct or consequential loss, including without limitation any loss of profits, arising from reliance on this Information. Neither Winvesta nor any of its affiliates are acting as an investment adviser, research analyst or in any other fiduciary capacity. Accordingly, reader’s are expected to undertake their own due diligence in consultation with their own advisors and are advised not to solely rely on the Information. Any such reliance shall be at the reader’s own risk. 

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing.


Start Building Your Global Portfolio Today

Download Winvesta App now to Get Started